Severe endothelial dysfunction in the aorta of a mouse model of Fabry disease; partial prevention by N-butyldeoxynojirimycin treatment.

Severe endothelial dysfunction in the aorta of a mouse model of Fabry disease; partial prevention by N-butyldeoxynojirimycin treatment.

OBJECTIVE: Fabry disease results from alpha-gala-ctosidase A deficiency and is characterized by the lysosomal accumulation of globotriaosylceramide. Globotriaosylceramide storage predominantly affects endothelial cells, altering vascular wall morphology and vasomotor function. Our objective was to i...

Бүрэн тодорхойлолт

Номзүйн дэлгэрэнгүй
Үндсэн зохиолчид:	Heare, T, Alp, N, Priestman, D, Kulkarni, AB, Qasba, P, Butters, T, Dwek, R, Clarke, K, Channon, K, Platt, F
Формат:	Journal article
Хэл сонгох:	English
Хэвлэсэн:	2007

Ижил төстэй зүйлс

N-butyldeoxynojirimycin causes weight loss as a result of appetite suppression in lean and obese mice.
-н: Priestman, D, зэрэг
Хэвлэсэн: (2008)

NSAIDs increase survival in the Sandhoff disease mouse: synergy with N-butyldeoxynojirimycin.
-н: Jeyakumar, M, зэрэг
Хэвлэсэн: (2004)

N-butyldeoxygalactonojirimycin: a more selective inhibitor of glycosphingolipid biosynthesis than N-butyldeoxynojirimycin, in vitro and in vivo.
-н: Andersson, U, зэрэг
Хэвлэсэн: (2000)

Long-term non-hormonal male contraception in mice using N-butyldeoxynojirimycin.
-н: Walden, C, зэрэг
Хэвлэсэн: (2006)

The alpha-glucosidase inhibitor N-butyldeoxynojirimycin inhibits human immunodeficiency virus entry at the level of post-CD4 binding.
-н: Fischer, P, зэрэг
Хэвлэсэн: (1995)

Novel oral treatment of Gaucher's disease with N-butyldeoxynojirimycin (OGT 918) to decrease substrate biosynthesis.
-н: Cox, T, зэрэг
Хэвлэсэн: (2000)

Sustained therapeutic effects of oral miglustat (Zavesca, N-butyldeoxynojirimycin, OGT 918) in type I Gaucher disease.
-н: Elstein, D, зэрэг
Хэвлэсэн: (2004)

Substrate reduction therapy in mouse models of the glycosphingolipidoses.
-н: Platt, F, зэрэг
Хэвлэсэн: (2003)

N -butyldeoxynojirimycin reduces growth and ganglioside content of experimental mouse brain tumours.
-н: Ranes, M, зэрэг
Хэвлэсэн: (2001)

Restricted ketogenic diet enhances the therapeutic action of N-butyldeoxynojirimycin towards brain GM2 accumulation in adult Sandhoff disease mice.
-н: Denny, C, зэрэг
Хэвлэсэн: (2010)

N-Butyldeoxynojirimycin is a broadly effective anti-HIV therapy significantly enhanced by targeted liposome delivery.
-н: Pollock, S, зэрэг
Хэвлэсэн: (2008)

Imino sugar therapy for type 1 Gaucher disease.
-н: Priestman, D, зэрэг
Хэвлэсэн: (2000)

Increased glycosphingolipid levels in serum and aortae of apolipoprotein E gene knockout mice.
-н: Garner, B, зэрэг
Хэвлэсэн: (2002)

Glycosphingolipid profiling of tissues from mouse models of human lysosomal storage disorders
-н: Priestman, D, зэрэг
Хэвлэсэн: (2008)

Increased endothelial tetrahydrobiopterin levels by GTPCH over expression in transgenic mice prevents diabetic endothelial dysfunction
-н: Alp, N, зэрэг
Хэвлэсэн: (2003)

Implications for invariant natural killer T cell ligands due to the restricted presence of isoglobotrihexosylceramide in mammals.
-н: Speak, A, зэрэг
Хэвлэсэн: (2007)

Serum Biomarkers of Endothelial Dysfunction in Fabry Associated Cardiomyopathy
-н: Jefferson Loso, зэрэг
Хэвлэсэн: (2018-08-01)

Endothelial Dysfunction in Fabry Disease Is Related to Glycocalyx Degradation
-н: Solvey Pollmann, зэрэг
Хэвлэсэн: (2021-11-01)

Increased glycosphingolipid levels in serum and aortae of apolipoprotein E gene knockout mice
-н: Brett Garner, зэрэг
Хэвлэсэн: (2002-02-01)

Effects of N-butyldeoxynojirimycin and the Lec3.2.8.1 mutant phenotype on N-glycan processing in Chinese hamster ovary cells: application to glycoprotein crystallization.
-н: Butters, T, зэрэг
Хэвлэсэн: (1999)

An MRI technique for the quantification of atherosclerotic lesions in the ApoE knockout mouse
-н: Grieve, S, зэрэг
Хэвлэсэн: (2002)

Anderson–Fabry Disease: From Endothelial Dysfunction to Emerging Therapies
-н: Cosimo A. Stamerra, зэрэг
Хэвлэсэн: (2021-01-01)

Inhibition of calcium uptake via the sarco/endoplasmic reticulum Ca2+-ATPase in a mouse model of Sandhoff disease and prevention by treatment with N-butyldeoxynojirimycin.
-н: Pelled, D, зэрэг
Хэвлэсэн: (2003)

High soluble endoglin levels do not induce endothelial dysfunction in mouse aorta.
-н: Ivana Nemeckova, зэрэг
Хэвлэсэн: (2015-01-01)

Endothelial nitric oxide synthase dysfunction in diabetic mice: importance of tetrahydrobiopterin in eNOS dimerisation.
-н: Cai, S, зэрэг
Хэвлэсэн: (2005)

Lucerastat, an iminosugar for substrate reduction therapy in Fabry Disease: Preclinical evidence
-н: Welford, R, зэрэг
Хэвлэсэн: (2017)

Antiviral effect of N-butyldeoxynojirimycin against bovine viral diarrhea virus correlates with misfolding of E2 envelope proteins and impairment of their association into E1-E2 heterodimers.
-н: Branza-Nichita, N, зэрэг
Хэвлэсэн: (2001)

Increased endothelial tetrahydrobiopterin synthesis by targeted transgenic GTP-cyclohydrolase I overexpression reduces endothelial dysfunction and atherosclerosis in ApoE-knockout mice.
-н: Alp, N, зэрэг
Хэвлэсэн: (2004)

N-butyldeoxynojirimycin delays motor deficits, cerebellar microgliosis, and Purkinje cell loss in a mouse model of mucolipidosis type IV
-н: Lauren C. Boudewyn, зэрэг
Хэвлэсэн: (2017-09-01)

Globotriaosylsphingosine accumulation and not alpha-galactosidase-A deficiency causes endothelial dysfunction in Fabry disease.
-н: Mehdi Namdar, зэрэг
Хэвлэсэн: (2012-01-01)

Regulation of endothelial nitric oxide synthase by tetrahydrobiopterin in vascular disease.
-н: Alp, N, зэрэг
Хэвлэсэн: (2004)

Chronic treatment with flavonoids prevents endothelial dysfunction in spontaneously hypertensive rat aorta
-н: Ajay, M., зэрэг
Хэвлэсэн: (2005)

Induction of Haemeoxygenase-1 Improves FFA-Induced Endothelial Dysfunction in Rat Aorta
-н: Fang Han, зэрэг
Хэвлэсэн: (2015-02-01)

Iminosugar inhibitors for treating the lysosomal glycosphingolipidoses
-н: Butters, T, зэрэг
Хэвлэсэн: (2005)

Therapeutic applications of imino sugars in lysosomal storage disorders.
-н: Butters, T, зэрэг
Хэвлэсэн: (2003)

Imino sugar inhibitors for treating the lysosomal glycosphingolipidoses.
-н: Butters, T, зэрэг
Хэвлэсэн: (2005)

New therapeutics for the treatment of glycosphingolipid lysosomal storage diseases.
-н: Butters, T, зэрэг
Хэвлэсэн: (2003)

Inhibition of glycosphingolipid biosynthesis: application to lysosomal storage disorders.
-н: Butters, T, зэрэг
Хэвлэсэн: (2000)

The apo E gene knockout mouse as a model to study the potential atherogenic properties of glycosphingolipids
-н: Garner, B, зэрэг
Хэвлэсэн: (2003)

Correction: Globotriaosylceramide Accumulation and Not Alpha-Galactosidase-A Deficiency Causes Endothelial Dysfunction in Fabry Disease
Хэвлэсэн: (2012-01-01)